ZSZhigang Song

Zhigang Song

*This is an algorithmically generated author record based on publicly available information.

Zhigang Song has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bluetongue in China: Current Status of Viruses, Vectors, Detection Methods, and Vaccines

    by Jige Xin, Xincheng Ji, Zhigang Song, Weidong Zuo, Shanglian Yin, Yong Peng, Miao Ren, Jun Ai, Diangang Han

    Bluetongue (BT) is a vector‐borne viral disease caused by the bluetongue virus (BTV), which can affect a variety of wild and domestic ruminants. Due to its significant impact on ruminant health and national economies, BT is classified as a notifiable multispecies disease by the World Organization for Animal Health (WOAH). In China, BT is listed as a Class II multispecies animal disease. This article provides a comprehensive review of the distribution of BTV and its primary insect vector, Culicoides , in China. Since BTV was first reported in China in 1979, BTV antibody‐positive samples have been detected in most parts of the country, with a total of 17 serotypes of BTV isolated (BTV‐1, 2, 3, 4, 5, 7, 9, 11, 12, 14, 15, 16, 17, 20, 21, 24, and 29). Culicoides are widely distributed across China. Currently, studies have been conducted on climatic factors influencing their distribution and blood‐sucking habits. To improve the efficiency of BTV detection in China, various detection methods have been explored, including polymerase chain reaction (PCR), loop‐mediated isothermal amplification (LAMP), bio‐bar code assay (BCA) for viral detection, as well as enzyme‐linked immunosorbent assay (ELISA), agar gel immunodiffusion (AGID) and colloidal gold immunochromatography test strips for antibody detection. Additionally, inactivated vaccines, attenuated vaccines, and recombinant vaccines were also investigated. This review summarizes the current knowledge on BTV vectors, viruses, and surveillance, as well as the development of BT vaccines in China. In light of the current situation of BT in China, it proposes comprehensive prevention and control recommendations, including enhancing awareness of the hazards of BT, implementing an integrated prevention and control technology system, and strengthening research related to BT prevention and control.


  • Open Access

    A novel quantitative real-time PCR with the GAPDH reference gene for peste des petits ruminants

    by Y Shi, D Han, J Li, L Ye, X Ji, F Nie, Z Song, C Chen, J Ai, J Xin

    Peste des petits ruminants (PPR) is?a?serious acute, highly contagious disease caused by?the peste des petits ruminants virus (PPRV). This study aims to?establish a?qRT-PCR assay with an?internal amplification control for the rapid and accurat...

  • Herpes Simplex Virus Type 1 Pneumonia—A Review

    by Marlene Ersgaard Jellinge, Frank Hansen, John Eugenio Coia, Zhijun Song

    Background: Pneumonia due to herpes simplex virus (HSV) is uncommon but can be seen in immunocompromised patients and has been associated with poor prognosis in this population. Aim: The aim was to study the results, outcome and mortality of HSV pneumonia in immunocompromised patients and patients receiving mechanical ventilation. Furthermore, it has been unclear whether to initiate prophylactic treatment with acyclovir or not. Methods: We have conducted a literature search using the keywords herpes simplex pneumonia, critically ill patients and intensive care unit for identification of relevant publications. Findings: HSV pneumonia can cause severe infection or even death in immunocompromised patients and critically ill patients. A clear diagnosis of HSV pneumonia can be difficult to establish. Respiratory condition may improve after initiation of acyclovir but data is scarce. Conclusion: HSV pneumonia should be considered in the immunocompromised patient and/or the intensive care patient who continues to deteriorate despite appropriate treatment. The value of prophylactic treatment with acyclovir is unproven but should be considered.